HIV vaccine: it may take two to tango, but no party time yet-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HIV vaccine: it may take two to tango, but no party time yet

Published:2009-10-09 Issue:1 Volume:6 Page:
ISSN:1742-4690
Container-title:Retrovirology
language:en
Short-container-title:Retrovirology

Author:

Berkhout Ben,Paxton William A

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Virology

Link

http://link.springer.com/content/pdf/10.1186/1742-4690-6-88.pdf

Reference12 articles.

1. Iaccino E, Schiavone M, Fiume G, Quinto I, Scala G: The aftermath of the Merck's HIV vaccine trial. Retrovirology. 2008, 5: 56-10.1186/1742-4690-5-56.

2. Thongcharoen P, Suriyanon V, Paris RM, Khamboonruang C, de Souza MS, Ratto-Kim S, Karnasuta C, Polonis VR, Baglyos L, Habib RE, Gurunathan S, Barnett S, Brown AE, Birx DL, McNeil JG, Kim JH: A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. J Acquir Immune Defic Syndr. 2007, 46: 48-55. 10.1097/QAI.0b013e3181576795.

3. Ready T: AIDSVAX flop leaves vaccine field unscathed. Nat Med. 2003, 9: 376-10.1038/nm0403-376a.

4. Desrosiers RC: Prospects for live attenuated HIV. Nature Medicine. 1998, 4: 982-10.1038/1949.

5. Berkhout B, Verhoef K, van Wamel JLB, Back B: Genetic instability of live-attenuated HIV-1 vaccine strains. J Virol. 1999, 73: 1138-1145.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic Acid Vaccines;Journal of Preventive, Diagnostic and Treatment Strategies in Medicine;2022-10

2. Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine;Journal of Chemical Technology & Biotechnology;2017-02-02

3. Vaccines for prevention of HIV infection;Cochrane Database of Systematic Reviews;2017-02-02

4. Vaccines for prevention of HIV infection;Cochrane Database of Systematic Reviews;2014-02-26

5. Liposomes for HIV prophylaxis;Biomaterials;2011-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3